http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 03 Jun 2026 17:28:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kuntz+Richard/26600447.html si-local-file:///var/storage/secattach/20260603/26600447.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kuntz+Richard/26600447.html Wed, 03 Jun 2026 17:28:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kuntz+Richard/26600447.html si-local-file:///var/storage/secattach/20260603/26600447.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kuntz+Richard/26600447.html Wed, 03 Jun 2026 17:28:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Giuffre+Randall+Michael/26600451.html si-local-file:///var/storage/secattach/20260603/26600451.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Giuffre+Randall+Michael/26600451.html Wed, 03 Jun 2026 17:28:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Giuffre+Randall+Michael/26600451.html si-local-file:///var/storage/secattach/20260603/26600451.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Giuffre+Randall+Michael/26600451.html Wed, 03 Jun 2026 17:28:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Lewis+Tanya/26600433.html si-local-file:///var/storage/secattach/20260603/26600433.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Lewis+Tanya/26600433.html Wed, 03 Jun 2026 17:27:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Lewis+Tanya/26600433.html si-local-file:///var/storage/secattach/20260603/26600433.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Lewis+Tanya/26600433.html Wed, 03 Jun 2026 17:27:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+O%26apos%3BConnor+Daniel+J./26600437.html si-local-file:///var/storage/secattach/20260603/26600437.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+O%26apos%3BConnor+Daniel+J./26600437.html Wed, 03 Jun 2026 17:27:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+O%26apos%3BConnor+Daniel+J./26600437.html si-local-file:///var/storage/secattach/20260603/26600437.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+O%26apos%3BConnor+Daniel+J./26600437.html Wed, 03 Jun 2026 17:27:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Semba+Charles+Pauling/26600427.html si-local-file:///var/storage/secattach/20260603/26600427.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Semba+Charles+Pauling/26600427.html Wed, 03 Jun 2026 17:26:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Semba+Charles+Pauling/26600427.html si-local-file:///var/storage/secattach/20260603/26600427.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Semba+Charles+Pauling/26600427.html Wed, 03 Jun 2026 17:26:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Pauls+Dietrich+John/26600394.html si-local-file:///var/storage/secattach/20260603/26600394.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Pauls+Dietrich+John/26600394.html Wed, 03 Jun 2026 17:24:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Pauls+Dietrich+John/26600394.html si-local-file:///var/storage/secattach/20260603/26600394.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Pauls+Dietrich+John/26600394.html Wed, 03 Jun 2026 17:24:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Parsons+James+T./26600400.html si-local-file:///var/storage/secattach/20260603/26600400.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Parsons+James+T./26600400.html Wed, 03 Jun 2026 17:24:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Parsons+James+T./26600400.html si-local-file:///var/storage/secattach/20260603/26600400.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Parsons+James+T./26600400.html Wed, 03 Jun 2026 17:24:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Krop+Julie/26600378.html si-local-file:///var/storage/secattach/20260603/26600378.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Krop+Julie/26600378.html Wed, 03 Jun 2026 17:23:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Krop+Julie/26600378.html si-local-file:///var/storage/secattach/20260603/26600378.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Krop+Julie/26600378.html Wed, 03 Jun 2026 17:23:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kellen+Scott/26600387.html si-local-file:///var/storage/secattach/20260603/26600387.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kellen+Scott/26600387.html Wed, 03 Jun 2026 17:23:00 -0400 DMAC O.02595765 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kellen+Scott/26600387.html si-local-file:///var/storage/secattach/20260603/26600387.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DiaMedica+Therapeutics++++For%3A+Jun+01++Filed+by%3A+Kellen+Scott/26600387.html Wed, 03 Jun 2026 17:23:00 -0400 DMAC O.02595765 http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the Company will present at the 2026 Jefferies Global Healthcare Conference being held in New York on June 2-4 2026. </p><p> <b>Jefferies Global Healthcare Conference</b> </p><p class="bwmarginl1"> <b>Date: </b>Thursday, June 4, 2026 <br /><b>Time:</b> 3:45 PM ET <br /><b>Format: </b>Corporate Presentation </p><p> If you are interested in arranging a 1×1 meeting with management, please contact your conference representative. </p><p> <b><i>About DiaMedica Therapeutics Inc.</i></b> </p><p> DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html Wed, 27 May 2026 16:30:00 -0400 A.50216777 DMAC O.02595765 O.54516537 http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the Company will present at the 2026 Jefferies Global Healthcare Conference being held in New York on June 2-4 2026. </p><p> <b>Jefferies Global Healthcare Conference</b> </p><p class="bwmarginl1"> <b>Date: </b>Thursday, June 4, 2026 <br /><b>Time:</b> 3:45 PM ET <br /><b>Format: </b>Corporate Presentation </p><p> If you are interested in arranging a 1×1 meeting with management, please contact your conference representative. </p><p> <b><i>About DiaMedica Therapeutics Inc.</i></b> </p><p> DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html Wed, 27 May 2026 16:30:00 -0400 A.50216777 DMAC O.02595765 O.54516537 http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the Company will present at the 2026 Jefferies Global Healthcare Conference being held in New York on June 2-4 2026. </p><p> <b>Jefferies Global Healthcare Conference</b> </p><p class="bwmarginl1"> <b>Date: </b>Thursday, June 4, 2026 <br /><b>Time:</b> 3:45 PM ET <br /><b>Format: </b>Corporate Presentation </p><p> If you are interested in arranging a 1×1 meeting with management, please contact your conference representative. </p><p> <b><i>About DiaMedica Therapeutics Inc.</i></b> </p><p> DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html Wed, 27 May 2026 16:30:00 -0400 A.50216777 DMAC O.02595765 O.54516537 http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the Company will present at the 2026 Jefferies Global Healthcare Conference being held in New York on June 2-4 2026. </p><p> <b>Jefferies Global Healthcare Conference</b> </p><p class="bwmarginl1"> <b>Date: </b>Thursday, June 4, 2026 <br /><b>Time:</b> 3:45 PM ET <br /><b>Format: </b>Corporate Presentation </p><p> If you are interested in arranging a 1×1 meeting with management, please contact your conference representative. </p><p> <b><i>About DiaMedica Therapeutics Inc.</i></b> </p><p> DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from http://www.streetinsider.com/Press+Releases/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html Wed, 27 May 2026 16:30:00 -0400 A.50216777 DMAC O.02595765 O.54516537 http://www.streetinsider.com/Business+Wire/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the Company will present at the 2026 Jefferies Global Healthcare Conference being held in New York on June 2-4 2026. </p><p> <b>Jefferies Global Healthcare Conference</b> </p><p class="bwmarginl1"> <b>Date: </b>Thursday, June 4, 2026 <br /><b>Time:</b> 3:45 PM ET <br /><b>Format: </b>Corporate Presentation </p><p> If you are interested in arranging a 1×1 meeting with management, please contact your conference representative. </p><p> <b><i>About DiaMedica Therapeutics Inc.</i></b> </p><p> DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from http://www.streetinsider.com/Business+Wire/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html Wed, 27 May 2026 16:30:00 -0400 A.50216777 DMAC O.02595765 O.54516537 http://www.streetinsider.com/Business+Wire/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the Company will present at the 2026 Jefferies Global Healthcare Conference being held in New York on June 2-4 2026. </p><p> <b>Jefferies Global Healthcare Conference</b> </p><p class="bwmarginl1"> <b>Date: </b>Thursday, June 4, 2026 <br /><b>Time:</b> 3:45 PM ET <br /><b>Format: </b>Corporate Presentation </p><p> If you are interested in arranging a 1×1 meeting with management, please contact your conference representative. </p><p> <b><i>About DiaMedica Therapeutics Inc.</i></b> </p><p> DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from http://www.streetinsider.com/Business+Wire/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html Wed, 27 May 2026 16:30:00 -0400 A.50216777 DMAC O.02595765 O.54516537 http://www.streetinsider.com/Business+Wire/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the Company will present at the 2026 Jefferies Global Healthcare Conference being held in New York on June 2-4 2026. </p><p> <b>Jefferies Global Healthcare Conference</b> </p><p class="bwmarginl1"> <b>Date: </b>Thursday, June 4, 2026 <br /><b>Time:</b> 3:45 PM ET <br /><b>Format: </b>Corporate Presentation </p><p> If you are interested in arranging a 1×1 meeting with management, please contact your conference representative. </p><p> <b><i>About DiaMedica Therapeutics Inc.</i></b> </p><p> DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from http://www.streetinsider.com/Business+Wire/DiaMedica+Therapeutics+to+Present+at+the+Jefferies+Global+Healthcare+Conference+2026/26558358.html Wed, 27 May 2026 16:30:00 -0400 A.50216777 DMAC O.02595765 O.54516537